|
MARCH6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.85000000000524E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.780800E-04 |
| Normal-vs-Stage2 |
5.007200E-04 |
| Normal-vs-Stage3 |
3.59109999999996E-05 |
| Normal-vs-Stage4 |
9.230400E-04 |
| Stage1-vs-Stage2 |
3.437600E-01 |
| Stage1-vs-Stage3 |
1.979240E-01 |
| Stage1-vs-Stage4 |
6.631000E-01 |
| Stage2-vs-Stage3 |
9.961200E-01 |
| Stage2-vs-Stage4 |
6.421000E-01 |
| Stage3-vs-Stage4 |
5.937000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.25290000000534E-05 |
| Normal-vs-AfricanAmerican |
1.329010E-01 |
| Normal-vs-Asian |
5.415900E-04 |
| Caucasian-vs-AfricanAmerican |
3.078200E-01 |
| Caucasian-vs-Asian |
6.661000E-01 |
| AfricanAmerican-vs-Asian |
2.258200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54231999999199E-05 |
| Normal-vs-Female |
1.845150E-04 |
| Male-vs-Female |
2.983000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.881880E-03 |
| Normal-vs-Age(41-60Yrs) |
7.65590000000316E-05 |
| Normal-vs-Age(61-80Yrs) |
4.20749999999748E-05 |
| Normal-vs-Age(81-100Yrs) |
6.513900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.928610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.906610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.668600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.733200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.943800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.545000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.844900E-04 |
| Classical-VS-Follicular |
4.315500E-03 |
| Classical-VS-Other |
2.625800E-01 |
| Classical-VS-Normal |
2.515500E-03 |
| Tall-VS-Follicular |
3.203200E-01 |
| Tall-VS-Other |
6.846200E-01 |
| Tall-VS-Normal |
5.35470000007088E-07 |
| Follicular-VS-Other |
8.898400E-01 |
| Follicular-VS-Normal |
1.96088999999677E-05 |
| Other-VS-Normal |
2.632400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65017999999018E-05 |
| Normal-vs-N1 |
1.318480E-02 |
| N0-vs-N1 |
1.777430E-01 |
|
|
